David A Mankoff

Title: David A. Mankoff: Innovator in Diagnostic Imaging

Introduction

David A. Mankoff is a prominent inventor based in Philadelphia, PA (US). He has made significant contributions to the field of diagnostic imaging, particularly through his innovative work on radiotracer derivatives of trimethoprim. With a total of 2 patents, Mankoff's inventions are paving the way for advancements in medical imaging techniques.

Latest Patents

Mankoff's latest patents focus on the development of radiolabeled trimethoprim, which is useful in imaging tests such as PET scans. These compounds demonstrate robust bacterial uptake in vitro and are capable of identifying infections from inflammation or tumors when administered to a subject. The inventions provide rapid and sensitive detection of Ec DHFR containing tumors, distinguishing them from control tumors and background tissue. The patents also include compositions containing these compounds, positron emission tomography reporter probes, and methods for imaging bacterial infections, tracking bacteria, and monitoring genetically engineered cells in clinical scenarios such as immunotherapy for cancer treatment.

Career Highlights

David A. Mankoff is affiliated with the University of Pennsylvania, where he continues to contribute to research and innovation in the field of diagnostic imaging. His work has garnered attention for its potential to improve patient outcomes through enhanced imaging techniques.

Collaborations

Mankoff has collaborated with notable colleagues, including Mark Sellmyer and Robert H. Mach, further enriching his research endeavors and expanding the impact of his inventions.

Conclusion

David A. Mankoff's innovative contributions to diagnostic imaging exemplify the importance of research and development in healthcare. His work not only advances medical technology but also holds the promise of improving diagnostic accuracy and patient care.